Search

Your search keyword '"Han‐Yun Ren"' showing total 93 results

Search Constraints

Start Over You searched for: Author "Han‐Yun Ren" Remove constraint Author: "Han‐Yun Ren"
93 results on '"Han‐Yun Ren"'

Search Results

1. The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

2. C–C chemokine receptor 5 and acute graft‐versus‐host disease

Catalog

Books, media, physical & digital resources

3. A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China

5. Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myeloma

6. Allogeneic Compact Bone-Derived Mesenchymal Stem Cell Transplantation Attenuates the Severity of Idiopathic Pneumonia Syndrome in a Murine Bone Marrow Transplantation Model

7. Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled Trials

8. Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis

9. Intrathecal CAR-NK cells infusion for isolated CNS relapse after allogeneic stem cell transplantation

10. Low-Dose 5-Aza and DZnep Alleviate Acute Graft-Versus-Host Disease With Less Side Effects Through Altering T-Cell Differentiation

11. Low-Dose 5-Aza and DZnep Alleviate Acute Graft

12. Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host Disease

13. [Clinical Analysis of Dasatinib and Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia]

14. [Analysis of Decitabine Therapeutic Effeicacy for Patients with Relapsed MDS/AML and High-Risk AML Patients after HSCT]

15. Author response for 'Establishment and characterization of a DOT1L inhibitor‐sensitive human acute monocytic leukemia cell line YBT‐5 with a novel KMT2A‐MLLT3 fusion'

16. [Preliminary Study on the Characteristic of Plasma Cytokine Profiles in Patients with Idiopathic Multicentric Castleman Diseases]

17. [Pathological Features, Treatment Options and Prognosis Assessment of Patients with Bone Lymphoma in Real-World]

18. [A Preliminary Study on the Expression of CD160 on NK Cells and Its Mechanism of Mediating NK Killing Effect]

19. [Incidence of Bone Marrow Involvement in Different Pathological Type Lymphoma Patients]

20. [Detecting HB-1 Expression Level in Bone Marrow of Acute Leukemia Patients by Real-Time Fluorescence Quantitative RT-PCR]

21. [Salvage Trerapy for Patients with Relapsed and Refractory Lymphoma by Allogeneic Hematopoietic Stem Cell Transplantation]

22. Compound heterozygous hemophilia A in a female patient and the identification of a novel missense mutation, p.Met1093Ile

23. [Clinical Research Progress on Transformed Lymphoma -Review]

24. [Comparison of CCR5 Expression on T Lymphocytes between the Bone Marrow and Peripheral Blood Grafts after Mobilization]

25. [Analysis of Clinical Efficacy and Prognosis in 83 Cases Receiving Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies]

26. [Clinical Analysis of Recombinant Human Thrombopoietin for Treatment of 46 Adult Patients with Newly Diagnosed Primary Immune Thrombocytopenia]

27. Irradiation of peripheral blood mononuclear cells with 7.5 Gy X-rays prior to donor lymphocyte infusion inhibits proliferation while preserving cytotoxicity, and improves the effectiveness of HSCT in patients with hematological malignancies

28. [Chemokine Receptor-5 and Graft-versus-Host Disease]

29. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

30. [Investigation of lymphoma patients' EBV infection status]

31. [Clinical characteristics and long-term follow-up of 29 patients with primary mediastinal large B cell lymphoma]

32. [Clinical and pathological analysis of 236 patients with primary extranodal lymphoma]

33. [Differential regulation of CCR5 expression on T lymphocytes in healthy donors after mobilization with rhG-CSF and its correlation with aGVHD]

34. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation]

35. [Analysis of L-asparaginase induced elevation of blood ammonia and hepatic encephalopathy]

36. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma]

37. [Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation]

38. [Combination of rituximab with autologous peripheral blood stem cell transplantation for treatment of diffuse large B-cell lymphoma: a single-center experience]

40. [Study on chronic health conditions and its related risk factors in recipients after hematopoietic stem cell transplantation]

41. [Quantitative monitoring of blood cytomegalovirus after allogeneic hematopoietic stem cell transplantation and its clinical significance]

42. [Clinical investigation of primary amyloidosis with autologous hematopoietic stem cell transplantation]

43. [Bone marrow-derived mesenchymal stem cells regulate the proliferation and activity of natural killer cells]

44. Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-gamma 1 in a human erythropoietin-dependent cell line

45. Long-term outcomes in adults with leukemia treated with transplantation of two unrelated umbilical cord blood units

47. [Application of SPECT/PET to 70 patients with lymphoma: monitoring response to therapy]

48. [Efficacy analysis of sequential treatment with chemotherapy, ATRA and As(2)O(3) for acute promyelocytic leukemia]

49. [Incidence and risk factors of hemorrhagic cystitis after hematopoietic stem cell transplantation]

50. [Application of SPECT/PET in patients with lymphoma and its significance in monitoring relapse]